Mohan Jitendra

CEO Mohan Jitendra sells 95,444 shares at blended avg $225.02 for $21,476,948.62

Mohan Jitendra, Chief Executive Officer, executed 17 separate sales on 2026-05-18 totaling 95,444 shares for $21,476,948.62, reducing his ALAB holdings by 6.6% to 1,357,295 shares post-transaction. The current stock price is $287.48, trading +9.4% above the 52-week high of $262.90, and has rallied +63.5% over the past 30 days and +116.8% over the past 90 days. At his prior 5 trades in ALAB, post-sale returns in the 90-day window were +21.8%, +22.5%, +20.1%, +19.3%, and +21.3%, with a timing pattern of 0 of 5 well-timed at the 90-day mark. The multi-transaction structure and volume, executed during a period of exceptional momentum, warrants attention to whether these sales reflect portfolio-level flows or discretionary positioning.

CEO Jitendra sells 139,951 shares for $31.3M across 22 transactions via pre-arranged 10b5-1 plan

Mohan Jitendra, Chief Executive Officer of Astera Labs, executed 22 separate sales totaling 139,951 shares for $31,295,011.82 at a blended average price of $223.61 over two trading days (May 18–19, 2026), reducing holdings from 3,929,183 shares to 3,789,232 shares. This transaction is part of a pre-arranged 10b5-1 trading plan adopted on 2025-12-01, meaning it was scheduled and not discretionary. His prior sells at Astera Labs show 30-day returns of +21.8%, +22.5%, +20.1%, +19.3%, and +21.3% from those May 7 sales, whereas his cross-ticker track record over 20 prior sells averaged +30.5% 30-day returns and +35.3% 90-day returns. The stock now trades at $287.48, up 9.4% from the 52-week high of $262.90 and up 63.5% over the past 30 days, after rising 115.1% annually in revenue and trading at a P/E of 184.28.

CEO Mohan Jitendra executes seven-transaction sell totaling 139,951 shares in profitable, high-growth company trading below 52-week highs.

CEO Mohan Jitendra sold nearly 140,000 shares across seven separate transactions, reducing his holdings by about three percent. This sale is notable because Astera Labs is a profitable company with strong year-over-year revenue growth, yet the stock has declined significantly from its 52-week high despite gaining substantially over the prior month. Jitendra's prior sales at this ticker have consistently been poorly timed—every one of his five prior ALAB exits was followed by stock appreciation rather than decline, suggesting he has not historically sold into strength. This current sale, executed at prices spanning a narrow range, adds to his pattern of open-market dispositions: he has now completed 166 open-market sales across his portfolio in the 36-month window with no offsetting open-market purchases. While the absolute dollar amount ($28 million) is material and triggered the filtering threshold for C-suite activity, the modest percentage reduction of holdings and the company's fundamentals suggest this is more of a routine monetization than a clear warning sign about company trajectory.

CEO Jitendra sold 335,881 shares ($57.9M) across 10 sales on 2026-04-17 to -04-20; now holds 4.07M shares post-transaction.

Mohan Jitendra, CEO of Astera Labs, executed 10 separate sales totaling 335,881 shares for $57,852,784.99 with a blended average price of $172.24 over two trading days (April 17–20, 2026), reducing his stake by 7.6%. The transaction occurred during a period of significant near-term price strength: the stock posted a 30-day return of +65.4% and is currently at $191.97, approximately 11% above the weighted average transaction price. Astera Labs is a high-growth company with annual revenue growth of +115.1% and a P/E of 65.07, indicating elevated valuation expectations. The CEO's prior cross-ticker trading history shows a 100% well-timed rate over 20 prior sells (avg 90-day return: -10.1%), though his ALAB-specific record at this single ticker shows no completed 90-day outcomes yet. This large, multi-day liquidation by the company's chief executive is material and warrants investor scrutiny regarding motivation and forward guidance.

Mohan Jitendra (CEO) sold 2,967 shares at blended avg $174.60 on 2026-04-15 for $518,036.21; post-transaction holding 4,405,015 shares.

CEO Mohan Jitendra executed 2 separate sales totaling 2,967 shares for $518,036.21 on 2026-04-15, representing -0.1% of his pre-transaction holding of 4,407,982 shares. The sale occurred at $174.57 and $175.03, slightly above the current price of $170.81 and approximately 30.6% below the 52-week high of $251.88. His cross-ticker track record shows a 100.00% well-timed rate across 20 prior sales with an average 90-day return of -10.4%, though at Astera Labs specifically, his 5 prior trades have not yet developed measurable 90-day outcomes, limiting sector-specific pattern assessment. The sale was modest relative to his substantial retained position, and the stock has gained 33.9% over the past 30 days, suggesting recent momentum in the name.

ALAB CEO Mohan Jitendra sells 123,750 shares for $18.5M at $149.68 average; stock now at $170.60

Mohan Jitendra, CEO of Astera Labs, executed 2 separate sales totaling 123,750 shares for $18,522,445.33 at a blended average price of $149.68 on 2026-04-10. At the current price of $170.60, the stock has risen 41.8% over the past 30 days and now trades 32.3% below its 52-week high of $251.88. His post-transaction holdings of 4,407,982 shares represent a 2.7% reduction from pre-transaction levels. The timing of this sale warrants scrutiny given that the stock now trades substantially above the transaction prices, and the company's fundamentals remain strong with $230.6M quarterly revenue and 115.1% annual revenue growth, though at a steep 57.83 P/E valuation.

CEO Mohan Jitendra sells 157,500 shares for $20.7M at ALAB on 2026-03-17; holds 4.53M shares post-sale

Mohan Jitendra executed 10 separate sales totaling 157,500 shares for $20,723,773.16 on 2026-03-17, reducing his holdings by 3.4% to 4,531,732 shares. The sales were spread across a range of prices from $125.56 to $133.66, with a blended average of $131.58, occurring when the stock trades at $126.16 currently—49.9% below its 52-week high of $251.88. His prior trades at ALAB (5 sales on 2026-02-17) showed mixed near-term performance: 30-day returns ranged from -0.1% to +3.3%, with no 90-day outcomes yet measurable. Across his broader open-market history, his 20 prior sells averaged +12.2% return in 30 days but only +1.9% over 90 days, with a 46.67% well-timed rate. The company's fundamentals show strong recent growth: revenue of $230,575,000.00 in the latest quarter, net income of $91,114,000.00, and annual revenue growth of +115.1%, though the elevated P/E of 42.77 reflects market expectations already baked into the stock's current depressed position relative to its recent highs.

CEO Jitendra sold 94,971 shares for $11,758,145.88; stock down -27.8% in 30 days, -47.4% from high.

Mohan Jitendra, CEO of Astera Labs, executed 5 separate sales totaling 94,971 shares for $11,758,145.88 on 2026-02-17, with prices ranging from $122.16 to $126.34. The stock has declined sharply since the transaction: -27.8% over the past 30 days and -47.4% from its 52-week high of $251.88, now trading at $132.62. Jitendra's prior 5 trades at ALAB were all well-timed on a 90-day basis, with negative returns ranging from -2.1% to -4.4% post-sale, suggesting consistent pattern recognition. The company's valuation remains elevated at a P/E of 112.39 despite unprofitability on a full-year basis, though quarterly net income stands at $91.1M on revenue of $230.6M with annual growth of 242.2%.

CEO Mohan Jitendra sells 90,459 shares ($13.1M) across 5 transactions on 2025-11-17 at $143.84–$146.65, stock down 9.2% (30d), -20.0% (90d).

Mohan Jitendra, Chief Executive Officer of Astera Labs, executed 5 separate sales totaling 90,459 shares for $13,088,903.90 on 2025-11-17, reducing his holdings from 2,170,877 to 2,080,418 shares (a -4.2% reduction). The sales occurred at prices ranging from $143.25 to $146.65 (blended average $144.69), compared to a current price of $142.01—slightly below the transaction blended average. Over the company's fundamental context, ALAB shows strong revenue growth (+242.2% annually) and recent profitability ($91.1M net income in the latest quarter), though it was unprofitable on a full-year basis, commanding a P/E of 120.35 on $24.0B market cap. The stock is down -43.6% from its 52-week high of $251.88, and in the 30 and 90 days following this filing date, returns would show -9.2% (30d) and -20.0% (90d), respectively. His prior 5 trades at ALAB (August 2025) showed mixed timing: 2 of 5 were well-timed at the 90-day mark. The sale's significance lies in the sheer dollar magnitude ($13.1M) and the CEO's willingness to reduce exposure during a period of stock weakness and despite strong near-term revenue fundamentals.

ALAB CEO Mohan Jitendra sells 91,441 shares for $16.8M at $183.51 blended avg; holds 2.17M shares post-sale.

Mohan Jitendra, Chief Executive Officer of Astera Labs, filed two separate sales on 2025-08-18 totaling 91,441 shares (91.4K shares) for $16,780,383.40 ($16.8M) at a blended average price of $183.51. The current price of $172.45 is 10.9% below the 52-week high of $193.64, yet the stock is up 41.5% over 30 days and 82.9% over 90 days, reflecting significant recent momentum. The sale reduces his holdings from 2,262,318 shares to 2,170,877 shares (2.17M shares), a 4.0% reduction. Notably, this sale occurs just 11 days after five other sales by the same insider on 2025-08-07, suggesting sustained liquidation activity during a period of elevated stock valuation and strong short-term price appreciation. The company's fundamentals show explosive revenue growth of 242.2% annually and net income of $51.2M on $191.9M revenue (latest quarter), though the company was unprofitable on a full-year basis, resulting in an elevated P/E of 287.42 on a market cap of $28.7B.